Moembris, Germany

Daniel Hofmann

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Albert Einstein College of Medicine. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Hofmann. Retrieved from https://idiyas.com/inventor/daniel-hofmann-dn589hsm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Hofmann

Introduction: Daniel Hofmann, an inventive mind from Moembris, Germany, has made significant strides in the field of biomedicine with an impressive portfolio of patents. With two notable patents to his name, he continues to push the boundaries of scientific innovation.

Latest Patents: Among his notable inventions, Hofmann has developed high-affinity capsule-specific human monoclonal antibodies. These innovative antibodies and their fragments are designed to improve medical interventions, offering methods of use and devices that utilize these specific antibodies. His breakthrough contributions may have profound implications for disease treatment and diagnostics.

Career Highlights: Daniel Hofmann is affiliated with the esteemed Albert Einstein College of Medicine, where he applies his expertise to advance medical research and therapeutics. His tenure at this institution has been characterized by a commitment to innovation, research, and the pursuit of effective medical solutions.

Collaborations: Throughout his career, Hofmann has collaborated with talented professionals in his field. Noteworthy colleagues include Jacqueline Michele Achkar and Jonathan R Lai, who share a similar passion for pioneering research and innovation in biomedicine. Together, they contribute to a collaborative environment that fosters groundbreaking advancements.

Conclusion: Daniel Hofmann represents a significant figure in the realm of biomedical inventions. His contributions, particularly in the development of high-affinity antibodies, exemplify the impact of dedicated research and innovation on healthcare. As he continues his work at the Albert Einstein College of Medicine, the future holds great promise for his ongoing contributions to science and medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…